Abstract
Chronic mucocutaneous candidiasis is characterized by infections caused by Candida sp, usually Candida albicans, which may be persistent or recurrent on skin, mucous membranes and nails; generally confined on the cutaneous surface and occasionally systemic dissemination. This can be associated to endocrinopathies and autoimmunity. We report a case of chronic mucocutaneous candidiasis with liver disease secondary to treatments with fluconazole, with positive response to topical treatments of itraconazole and others, as well as immunostimulation.
Publisher
Salud, Ciencia y Tecnologia
Reference24 articles.
1. 1. Chávez MC, Marcelo JL, Gómez Y, González A, Pérez T. Candidiasis mucocutánea crónica. A propósito de un caso. Revista cubana de hematología, inmunología y hemoterapia. 2017;36(suplemento):1-6.
2. 2. Flores C, Bonifaz A. Aspectos inmunológicos de la candidosis mucocutánea crónica. Dermatología Cosmética, Médica y Quirúrgica [Internet]. 2020;18(4):296–305. Available from: https://www.medigraphic.com/pdfs/cosmetica/dcm-2020/dcm204l.pdf.
3. 3. Shafer S, Yao Y, Comrie W, Cook S, Zhang Y, Yesil G. Two patients with chronic mucocutaneous candidiasis caused by TRAF3IP2 deficiency. Rev J Allergy Clin Immunol. 2021;148(1):256-61.
4. 4. Marujo F, Pelham SJ, Freixo J, Cordeiro AI, Martins C, Casanova JL. A Novel TRAF3IP2 Mutation Causing Chronic Mucocutaneous Candidiasis. Rev J ClinImmunol. 2021;41(6):1376-9.
5. 5. Frede N, Rojas-Restrepo J, Caballero Garcia de Oteyza A, Buchta M, Hübscher K, Gámez-Díaz L. Genetic Analysis of a Cohort of 275 Patients with Hyper-IgE Syndromes and/or Chronic Mucocutaneous Candidiasis. Rev J ClinImmunol. 2021;41(8):1804-38.